Systematic symptom management in the IMPACT Consortium: Rationale and design for 3 effectiveness-implementation trials Review


Authors: Smith, A. W.; DiMartino, L.; Garcia, S. F.; Mitchell, S. A.; Ruddy, K. J.; Smith, J. D.; Wong, S. L.; Cahue, S.; Cella, D.; Jensen, R. E.; Hassett, M. J.; Hodgdon, C.; Kroner, B.; Osarogiagbon, R. U.; Popovic, J.; Richardson, K.; Schrag, D.; Cheville, A. L.; on behalf of the IMPACT Consortium
Review Title: Systematic symptom management in the IMPACT Consortium: Rationale and design for 3 effectiveness-implementation trials
Abstract: Cancer and its treatment produce deleterious symptoms across the phases of care. Poorly controlled symptoms negatively affect quality of life and result in increased health-care needs and hospitalization. The Improving the Management of symPtoms during And following Cancer Treatment (IMPACT) Consortium was created to develop 3 large-scale, systematic symptom management systems, deployed through electronic health record platforms, and to test them in pragmatic, randomized, hybrid effectiveness and implementation trials. Here, we describe the IMPACT Consortium's conceptual framework, its organizational components, and plans for evaluation. The study designs and lessons learned are highlighted in the context of disruptions related to the COVID-19 pandemic. © 2023 Published by Oxford University Press.
Journal Title: JNCI Cancer Spectrum
Volume: 7
Issue: 6
ISSN: 2515-5091
Publisher: Oxford University Press  
Date Published: 2023-12-01
Start Page: pkad073
Language: English
DOI: 10.1093/jncics/pkad073
PUBMED: 37930033
PROVIDER: scopus
PMCID: PMC10627528
DOI/URL:
Notes: Review -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Deborah Schrag
    229 Schrag